Ketoconazole (kee-ta-KOE-na-zol), generic name for Nizoral, is an oral drug approved by the FDA for the use to treat fungal infections. However, it has been shown that higher doses of ketoconazole (800-1200mg/day vs 200-400mg/day) also block the production of both free and bound testosterone. Since high-dose Ketoconazole (HDK) has testosterone lowering effects, operating both on [...]
Oh no, another not so very clear issue for men with prostate cancer has emerged! According to an article written by Tara Parker-Pope in the New York Times, bisphosphonates (i.e. Fosamax), has been reported, in some rare occasions, to actually cause weaker bones that lead to an unusual type of fracture of the femur. Bisphosphonates [...]
Yesterday afternoon Senators Harkin and Specter introduced a landmark supplemental funding bill for the NIH. The Senator's bill proposes providing the National Cancer Institute with an additional $1.2 billion and the rest of the National Institutes of Health with $4 billion for FY 2008. This bill stems from their concern about the inadequate funding for [...]
A short time ago, I asked you to write to your legislators and encourage them to increase the nation's investment in cancer research and early detection programs in the federal government's 2009 budget. This funding is crucial to discovering and delivering the cures that we so desperately need. Thanks to your efforts, both the Senate [...]
According to Philip M. Arlen, M.D., director of the Clinical Research Group for the Laboratory of Tumor Immunology and Biology, Center for Cancer Research, at the National Cancer Institute, "Vaccines, if and when they are approved, can be safely and effectively combined with other therapies, including hormones. There appears to be an advantage in overall [...]